ClinicalTrials.Veeva

Menu

Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Upper Limb: a Double-blind Randomized Clinical Trial

U

University of Malaga

Status

Not yet enrolling

Conditions

Musculoskeletal Disorders
Upper Limb
Neuromodulation

Treatments

Other: Physical Exercise
Other: Neuromodulation
Other: Stretching

Study type

Interventional

Funder types

Other

Identifiers

NCT07165392
152/2025

Details and patient eligibility

About

This project aims to analyze the use of neuromodulation within a treatment protocol for musculoskeletal conditions of the upper limb, as well as to determine the difference between two and three sessions per week. Study participants will be divided into four intervention groups: the first will receive two sessions per week for a period of six months, while the second will receive three sessions per week for the same period. The treatment protocol will consist of therapeutic physical exercise focused on the muscles and joints of the lower limb, stretching of the involved muscles, and neuromodulation of the brachial plexus nerve root, which innervates the affected structures. The third and fourth intervention groups will receive the same treatment as mentioned above, but without neuromodulation. The third group will receive three sessions per week, while the second group will receive two sessions per week. Two different types of measurement variables will be used: objective variables will be used to measure range of motion and muscle strength. Subjective variables will also be used through validated questionnaires, covering physical activity, health-related quality of life, upper limb function, and a visual analog scale for pain perception.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants in the study will be men and women of working age, diagnosed with musculoskeletal disorders of the upper limb, and who have not yet received physical therapy.

Exclusion criteria

  • Have undergone surgery.
  • Those who refuse to participate in this study.
  • Patients who present muscular atrophy in the upper limb due to a pathology of the latter.
  • Medical conditions that are contraindications for neuromodulation therapy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 4 patient groups

Neuromodulation 2 times per week
Experimental group
Treatment:
Other: Stretching
Other: Neuromodulation
Other: Physical Exercise
Neuromodulation 3 times per week
Experimental group
Treatment:
Other: Stretching
Other: Neuromodulation
Other: Physical Exercise
Non-neuromodulation 2 times per week
Experimental group
Treatment:
Other: Stretching
Other: Physical Exercise
Non-neuromodulation 3 times per week
Experimental group
Treatment:
Other: Stretching
Other: Physical Exercise

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems